Markets:

Overview

News

Currencies

International

Treasuries

Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

4.570 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 3, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Anavex Life Sciences Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

AVXL INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Anavex Life Sciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

March 19, 2024

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hut 8, and Anavex and Encourages Investors to Contact the Firm

March 18, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Anavex Life Sciences Corporation Stockholder Alert: Robbins LLP Reminds Investors of AVXL Class Action

March 18, 2024

From Robbins LLP

Via Business Wire

Earnings Scheduled For February 7, 2024 ↗

February 07, 2024

Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.

Via Benzinga

Anavex Life Sciences Earnings Preview ↗

February 06, 2024

Via Benzinga

ANAVEX LIFE SCIENCES CORPORATION (NASDAQ: AVXL) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Anavex Life Sciences Corporation

March 18, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

ANAVEX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Anavex Life Sciences Corp. and Encourages Investors to Contact the Firm

March 14, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Anavex Life Sciences Corporation (AVXL)

March 14, 2024

From Robbins LLP

Via GlobeNewswire

Peering Into Anavex Life Sciences's Recent Short Interest ↗

January 24, 2024

Via Benzinga

Here's How Much You Would Have Made Owning Anavex Life Sciences Stock In The Last 5 Years ↗

January 23, 2024

Via Benzinga

AVXL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

March 14, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

ANAVEX LIFE SCIENCES CORPORATION SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Anavex Life Sciences Corporation (NASDAQ: AVXL)

March 14, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

Class Action Lawsuit Filed on Behalf of Anavex Life Sciences Corp. (AVXL) Investors - Nationally Ranked Investors Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

March 14, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,400 Today ↗

January 18, 2024

Via Benzinga

Anavex Life Sciences Stock Sees RS Rating Jump To 86; Is It One To Watch? ↗

December 20, 2023

A Relative Strength Rating upgrade for Anavex Life Sciences shows improving technical performance.

Via Investor's Business Daily

March 14, 2024

ATLANTA, GA - (NewMediaWire) - March 14, 2024 - A shareholder class action lawsuit has been filed against Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL). The lawsuit alleges that...

Via TheNewswire.com

Topics Fraud Lawsuit

AVXL INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Anavex Life Sciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

March 14, 2024

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday ↗

January 03, 2024

U.S. stocks traded lower, with the Nasdaq Composite falling around 150 points on Wednesday. Shares of TDCX Inc. (NYSE: TDCX) rose sharply during Wednesday’s session after it disclosed receiving a...

Via Benzinga

Topics Stocks

Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 03, 2024

Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) fell sharply during Wednesday’s session after Keefe, Bruyette & Woods downgraded rating on the stock.

Via Benzinga

Crude Oil Down 2%; Tesla Deliveries Top Estimates ↗

January 02, 2024

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling more than 250 points on Tuesday. The Dow traded up 0.01% to 37,691.77 while the NASDAQ fell 1.78% to...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 02, 2024

Via Benzinga

Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 02, 2024

Shares of Longboard Pharmaceuticals, Inc.

Via Benzinga

Dow Turns Higher; Anavex Life Sciences Shares Plunge ↗

January 02, 2024

U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 50 points on Tuesday. The Dow traded up 0.13% to 37,739.18 while the NASDAQ fell 1.29% to 14,818.23. The S&P 500...

Via Benzinga

Topics Stocks

Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday ↗

January 02, 2024

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.

Via Benzinga

Topics Stocks

Dow Down 100 Points; US Manufacturing PMI Falls In December ↗

January 02, 2024

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.28% to 37,584.41 while the NASDAQ...

Via Benzinga

Topics Stocks

Why Clinical Stage Biopharmaceutical Company Anavex Shares Are Tanking Today ↗

January 02, 2024

Anavex Life Sciences Corp. (NASDAQ: AVXL) shares are trading lower in the premarket session on Tuesday after the company provided an

Via Benzinga

Crude Oil Falls; RedHill Biopharma Shares Spike Higher ↗

November 27, 2023

U.S. stocks traded mixed toward the end of trading on Monday. The Dow traded down 0.13% to 35,344.56 while the NASDAQ rose 0.11% to 14,266.69. The S&P 500 also fell, dropping, 0.08% to 4,555.47.

Via Benzinga

Topics Stocks

Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

November 27, 2023

Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the company reported fourth-quarter financial results.

Via Benzinga

Wall Street Slumps As "Fear Gauge" Mounts Comeback ↗

November 27, 2023

Wall Street is placing its four-week rally on hold, as investors watch the retail sector following an online record-setting Black Friday and await this week's slew of economic data.

Via Talk Markets

Nasdaq Moves Higher; US New Home Sales Fall In October ↗

November 27, 2023

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite moving higher on Monday. The Dow traded down 0.23% to 35,310.40 while the NASDAQ rose 0.21% to 14,280.12. The S&P 500 also...

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.